Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of DW1125 and DW1125A in Hypercholesterolemia
NCT05970679Phase 3Completed
- Sponsor
- Daewon Pharm
- Start
- Aug 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ezetimibe, atorvastatin in hypercholesterolemia, mixed dyslipidemia, sponsored by Daewon Pharm. Started Aug 2022; status: completed.
02
Drugs
ezetimibeatorvastatin
03
Conditions
hypercholesterolemiamixed dyslipidemia
Beyond the preview
Go deeper on NCT05970679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05970679.